AIRS
What one share of AirSculpt Technologies holds
Services – Offices and Clinics of Doctors of Medicine
AirSculpt is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin, while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results.
AirSculpt Technologies’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $2.28 |
|---|---|
| Profit | −$0.18 |
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | $0.01 |
| Cash and investments | $0.26 |
| Debt | $0.61 |
| Book value | $1.47 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2022 | $3.03 | −$0.26 | $0.23 | $0.21 | $0.41 | $1.26 |
| 2023 | $3.45 | −$0.07 | $0.17 | $0.25 | — | $1.44 |
| 2024 | $3.13 | −$0.14 | $0.24 | −$0.05 | — | $1.34 |
| 2025 | $2.51 | −$0.19 | $0.04 | $0.01 | — | $1.36 |